The Acute Leukemia MRD Panel is used to detect and quantify minimal residual disease (MRD) in patients with acute leukemia. MRD refers to the persistence of a small number of leukemia cells after initial treatment. This test helps assess the effectiveness of therapy, predict the risk of relapse, and guide treatment decisions.
Bone Marrow Fluids, Blood
At Redcliffe Labs, we have a single goal: to give India its right to quality diagnostics.
Customers served
Tests Processed Everyday
Cities
Collection Centres
World Class In-house Labs
Home Collection Experts